<DOC>
	<DOCNO>NCT00545610</DOCNO>
	<brief_summary>The purpose 12-month , observational , follow-up study collect additional data ( telephone contact ) ass efficacy , safety , effect intramyocardial injection adult autologous CD34+ cell quality life ( QoL ) subject chronic refractory myocardial ischemia . No treatment administer study . However , investigator study site personnel subject remain blinded treatment assignment core therapeutic study ( # 24779 ) provide total 24 month blind data .</brief_summary>
	<brief_title>ACT34-CMI -- Adult Autologous CD34+ Stem Cells ( Follow-Up Study )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Subjects receive treatment AutoCD34+ cell placebo complete final study visit ( Month 12 ) core therapeutic study 24779 Subjects willing comply specify followup evaluation study provide write informed consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>